Hosted By
In this special Cambridge Tech Week podcast episode we chat to Umaima Ahmad, CEO and co-founder of 52North, a multi-award winning med-tech company focused on reinventing the healthcare journey, starting by transforming cancer care with Neutrocheck®. She shares lessons learned from the early days of Neutrocheck to the company recently being the first ever venture investment of Macmillan Cancer Support.
Hear how Umaima moved from a successful career as a finance lawyer into the world of entrepreneurship and healthcare, via her role in business development at AstraZeneca. She tells us about how the idea came about, the importance of good hires and provides some tips on securing early investors.
Today on the podcast, we’re joined by Dr Jon Moore — a biochemist, entrepreneur, and seasoned biotech leader whose career spans both cutting-edge academic...
Tristram Norman is co-founder and CTO of Simprints, a non-profit tech start-up building identification tools for the developing world – their mission is to...
Leo Rayman, founder and CEO of EdenLab speaks to Ben Hartley and shares his unique perspective as an “eco-capitalist,” advocating for the commercialization of...
